1. Home
  2. RVPH vs INVE Comparison

RVPH vs INVE Comparison

Compare RVPH & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • INVE
  • Stock Information
  • Founded
  • RVPH 2006
  • INVE 1990
  • Country
  • RVPH United States
  • INVE United States
  • Employees
  • RVPH N/A
  • INVE N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • RVPH Health Care
  • INVE Technology
  • Exchange
  • RVPH Nasdaq
  • INVE Nasdaq
  • Market Cap
  • RVPH 88.0M
  • INVE 86.5M
  • IPO Year
  • RVPH N/A
  • INVE 1997
  • Fundamental
  • Price
  • RVPH $1.80
  • INVE $3.51
  • Analyst Decision
  • RVPH Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • RVPH 5
  • INVE 2
  • Target Price
  • RVPH $11.40
  • INVE $7.25
  • AVG Volume (30 Days)
  • RVPH 1.6M
  • INVE 34.7K
  • Earning Date
  • RVPH 11-14-2024
  • INVE 03-11-2025
  • Dividend Yield
  • RVPH N/A
  • INVE N/A
  • EPS Growth
  • RVPH N/A
  • INVE N/A
  • EPS
  • RVPH N/A
  • INVE 3.10
  • Revenue
  • RVPH N/A
  • INVE $104,217,000.00
  • Revenue This Year
  • RVPH N/A
  • INVE N/A
  • Revenue Next Year
  • RVPH N/A
  • INVE N/A
  • P/E Ratio
  • RVPH N/A
  • INVE $1.13
  • Revenue Growth
  • RVPH N/A
  • INVE 70.57
  • 52 Week Low
  • RVPH $0.60
  • INVE $2.95
  • 52 Week High
  • RVPH $4.50
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 45.36
  • INVE 44.12
  • Support Level
  • RVPH $1.97
  • INVE $3.41
  • Resistance Level
  • RVPH $2.14
  • INVE $3.67
  • Average True Range (ATR)
  • RVPH 0.16
  • INVE 0.19
  • MACD
  • RVPH -0.02
  • INVE 0.01
  • Stochastic Oscillator
  • RVPH 29.29
  • INVE 27.91

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: